Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

ClinicalTrials.gov ID: NCT05401565

Public ClinicalTrials.gov record NCT05401565. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 11, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Multicenter Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy and safety of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults with PTSD.

Study identification

NCT ID
NCT05401565
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
29 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2022
Primary completion
Oct 4, 2023
Completion
Oct 4, 2023
Last update posted
Apr 17, 2024

2022 – 2023

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Alea Research Phoenix Arizona 85012
CITrials, Inc. Bellflower California 90706
ASCLEPES Research Centers Panorama City California 91402
Clinical Innovations, Inc Santa Ana California 92705
Sarkis Clinical Trials Gainesville Florida 32607
Galiz Research, LLC Hialeah Florida 33016
Florida International Research Center Miami Florida 33173
American Medical Research, Inc Oak Brook Illinois 60523
Boston Clinical Trials & Medical Research Roslindale Massachusetts 02135
Michigan Clinical Research Institute PC - Clinedge - PPDS Ann Arbor Michigan 48105
Va Medical Center Minneapolis Minnesota 55417
Alivation Research, LLC Lincoln Nebraska 68526
Bioscience Research, LLC New York New York 10016
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Donald J. Garcia Jr., MD, PA Austin Texas 78737

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05401565, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2024 · Synced Sep 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05401565 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →